Roundup Cancer Ruling Knocks 10% of Bayer's Shares
Roundup Cancer Ruling Knocks 10% of Bayer's Shares
GALWAY, IRELAND--August 20, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--German pharmaceuticals and chemicals major Bayer AG (Leverkusan, Germany) saw 10% knocked off the value of its share price after a U.S. court ruled that the Roundup weedkiller was responsible for causing cancer in a groundskeeper.
Within this article: Details court ruling, affected products, potential financial and sales impact
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects